Stocks›Technology›HAE

HAE

Name: AlgoThesis
Author: algothesis

HAEMONETICS CORPORATION

NYSEResearch view

Technology · Surgical & Medical Instruments & Apparatus · SEC EDGAR FY 2026-03-28

Price history

Interactive · live data via TradingView

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2026-03-28

Revenue$1.3B

Net Income$97,308

Gross Profit$787.6M

Oper Income$156.7M

EPS (dil)$2.05

Rev/sh$29.35

FCF/sh$5.73

Book/sh$17.52

Cash/sh$5.40

40+ fundamentals from SEC EDGAR (public domain) — deeper than a typical screener's ratio table.

Revenue & Earnings — fiscal year

$993.2M

2022

$1.2B

2023

$1.3B

2024

$1.4B

2025

$1.3B

2026

Financials — annual

SEC EDGAR · last 5 FY

USD	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$993.2M	$1.2B	$1.3B	$1.4B	$1.3B
Gross Profit	$505.5M	$615.1M	$691.5M	$749.0M	$787.6M
Operating Income	$80.8M	$156.0M	$164.9M	$221.8M	$156.7M

Deep dive

Computed from the SEC EDGAR multi-year statements

Operating leverage — margins

GrossOperatingNet

COMMUNITY · $HAE0 theses

POST YOUR TAKE →

Related Stocks

Loading peers…

Ask AI about HAE Build basket with HAE Screener

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.

HAE HAEMONETICS CORPORATION Stock — fundamentals, financials & AI research · AlgoThesis

HAE

Price history

Snapshot

Financials — annual

Deep dive

Operating leverage — margins

FY26 cash-flow waterfall